InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Vairavan Latha, 首席财务官. Insider active across 1 company, notably Arcutis Biotherapeutics, Inc.. Cumulatively, 7 reports have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €66k. History available since 6 May 2025. The latest transaction was filed on 11 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Vairavan Latha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
435 股@ US$21.050.0003% mcap11.2% 占其流量Common StockSEC:0002065881-26-000004:0
1,341 股@ US$23.61060.0010% mcap38.8% 占其流量Common StockSEC:0002065881-26-000002:0
27,000 股0Common StockSEC:0001628280-26-014325:0
1,320 股@ US$25.498442.9% 占其流量Common StockSEC:0001628280-26-005568:0
88 股@ US$24.71855.0% 占其流量Common StockSEC:0002065881-25-000035:0
89 股@ US$14.32661.6% 占其流量Common StockSEC:0001787306-25-000117:0
20,000 股0Common StockSEC:0002065881-25-000005:0
7 条申报中的 7 条
About Vairavan Latha
Vairavan Latha is the Chief Financial Officer at Arcutis Biotherapeutics, Inc. She is responsible for the company's financial management, overseeing accounting operations and financial planning. Her role is crucial in ensuring Arcutis's financial health and supporting strategic decision-making. Through her expertise, she contributes to the company's growth and sustainability.
